Current market catalysts

Piper Sandler Maintains Neutral on Li Auto, Lowers Price Target to $13

Piper Sandler analyst Alexander Potter maintains Li Auto (NASDAQ:LI) with a Neutral and lowers the price target from $15 to $13.

Piper Sandler Reiterates Overweight on Mesoblast, Raises Price Target to $39

Piper Sandler analyst Edward Tenthoff reiterates Mesoblast (NASDAQ:MESO) with a Overweight and raises the price target from $35 to $39.

Nvidia's Best Day Since April 2025, Cybersecurity Stocks Go Vertical: Stock Market Today

Nvidia surged 9% and cybersecurity names exploded higher, yet 10 of 11 S&P 500 sectors fell as yields firmed before Jackson Hole.

HP Analysts Boost Their Forecasts After Better-Than-Expected Q3 Results

HP Inc. (HPQ) posted strong Q3 results, beating estimates and raising its FY2026 earnings forecast. Analysts have mixed opinions on the stock.

BlackBerry shares are trading higher after the company announced that its QNX division revealed support for the Hailo-8 AI Accelerator on QNX Software Development Platform 8.0.

This Waters Analyst Turns Bullish; Here Are Top 3 Upgrades For Thursday

Top Wall Street analysts upgraded BWX Technologies, The Macerich Company, and Waters Corporation. Check out analyst ratings and price targets.

The IV Crush Is Only Half The Story: How Options Get So Expensive Before Earnings

Before the IV crush comes the IV rush. Data on Salesforce, Intel and NVIDIA shows how implied volatility climbs into earnings — and why option prices don't follow.

8-K filing — Federal Home Loan Bank of Des Moines

Filed: 2026-08-27 AccNo: 0001325814-26-000134 Size: 184 KB Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 9.01: Financial Statements and Exhibits

Why Is Adobe Stock Surging on Thursday?

Adobe Inc (NASDAQ: ADBE) stock is trading higher Thursday following quarterly earnings results from Salesforce Inc (NYSE: CRM).

Veeva Stock Takes Off After Best CRM Quarter Ever: Analysts Approve

Veeva shares surge after Q2 adjusted EPS and revenue beat estimates, while analysts raise price targets on stronger CRM momentum and guidance.

Piper Sandler Maintains Overweight on Curbline Properties, Lowers Price Target to $39

Piper Sandler analyst Alex Goldfarb maintains Curbline Properties (NYSE:CURB) with a Overweight and lowers the price target from $40 to $39.

Live On Fox Business, Fed's Hammack Says The Job Market Is Broadly In Balance; Latest Inflation Data In Line With Expectations; Fed Policy Needs To Be Restrictive; Expects Slow Progress On Inflation, Should End Year Around 3%; Next Year Inflation Might Ease To Around 2.5% 'At Best'; Goes Into Every Fed Meeting With An Open Mind; Says Open Minded About Cadence Of Fed Meeting Schedules

Piper Sandler Maintains Overweight on BXP, Lowers Price Target to $88

Piper Sandler analyst Alexander Goldfarb maintains BXP (NYSE:BXP) with a Overweight and lowers the price target from $90 to $88.

The Capitol Forum Posts On X "Chemed: Vitas Healthcare Misdiagnosed Dementia Patients and 'Fudged' Evaluation Scores in Order to Admit Them into Hospice; Expert Who Reviewed Internal Documents Says They Warrant Federal Investigation"

https://x.com/Capitol_Forum/status/2093021234103488646

8-K filing — Federal Home Loan Bank of Boston

Filed: 2026-08-27 AccNo: 0001331463-26-000168 Size: 161 KB Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

When Revolution Medicines' FDA Win Lifts Other Boats: SELLAS Life Sciences Stock Surges

SELLAS stock gains momentum following FDA approval for Revolution Medicines, highlighting SLS009 preclinical pancreatic cancer data.

FactSet Research Systems shares are trading higher after RBC Capital raised its price target on the stock from $240 to $304.

T3 Defense shares are trading higher. The company recently announced its subsidiary, Tiltan Software Engineering, has been selected by a sensor systems developer and manufacturer to license Majestic.ai.

'U.S. Close To Striking "Massive" Deal For Venezuelan Oil Fields' - Axios

https://www.axios.com/2026/08/27/trump-venezuela-oil-deal-talks

Hyperliquid Strategies Q4 EPS $6.24, Sales $6.334M Beat $3.000M Estimate

Hyperliquid Strategies (NASDAQ:PURR) reported quarterly earnings of $6.24 per share which beat the analyst consensus estimate of $0.79 by 689.87 percent. The company reported quarterly sales of $6.334 million which

Artelo Biosciences shares are trading lower after the company announced a 1-for-9 reverse stock split.

10 Industrials Stocks Moving In Thursday's Intraday Session

Gainers Mint (NASDAQ:MIMI) shares rose 45.5% to $2.62 during Thursday's regular session. The company's market cap stands at $24.1 million. BrenX (NASDAQ:BRNX) stock increased by 32.29% to $8.26. The market

11 Consumer Discretionary Stocks Moving In Thursday's Intraday Session

Gainers Worksport (NASDAQ:WKSP) stock increased by 33.8% to $0.68 during Thursday's regular session. The market value of their outstanding shares is at $7.8 million. Golden Sun Technology (NASDAQ:GSUN) stock

12 Health Care Stocks Moving In Thursday's Intraday Session

Gainers Celularity (NASDAQ:CELU) stock moved upwards by 134.0% to $2.06 during Thursday's regular session. The company's market cap stands at $25.0 million. Propanc Biopharma (NASDAQ:PPCB) stock increased by

12 Information Technology Stocks Moving In Thursday's Intraday Session

Gainers Amplitech Group, Inc. - Series B Right (NASDAQ:AMPGZ) shares rose 53.2% to $0.33 during Thursday's regular session. ChowChow Cloud Intl (AMEX:CHOW) stock increased by 37.68% to $0.52. The market value of

Salesforce Stock Rockets 20% on Anthropic Windfall, Guidance Raise

Salesforce stock surges 20% on Q2 beat, raised outlook and its partnership with Anthropic on Claudeforce dispels SaaSpocalypse fears.

ServiceNow Stock Jumps on Enterprise AI Momentum

ServiceNow stock jumps 9% following strong Salesforce Q2 earnings, an enterprise AI momentum boost, and positive analyst price target upgrades.

Nexa Resources shares are trading lower after the company announced that Votorantim S.A. has entered into a definitive agreement with Boliden AB for the sale of its controlling stake in Nexa.

Piper Sandler Maintains Neutral on Lineage, Lowers Price Target to $44

Piper Sandler analyst Alexander Goldfarb maintains Lineage (NASDAQ:LINE) with a Neutral and lowers the price target from $46 to $44.

C3is shares are trading lower after the company reported Q2 financial results. The company attributed bunker costs for the rise of voyage and vessels’ operating expenses.